FDA Approved: BRINEURA — Supplemental Application (BioMarin Pharmaceutical Inc.)

View source ↗

Summary

The FDA approved a supplemental application for BRINEURA (cerliponase alfa) from BioMarin Pharmaceutical Inc., updating the drug’s approved indication and/or la…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cln2 Disease
• Neuronal Ceroid Lipofuscinosis Type

Drugs mentioned

• BRINEURA (cerliponase alfa)

Snippet

SUPPL AP for BRINEURA (CERLIPONASE ALFA)